Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.

Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.

Item
http://www.wikidata.org/entity/Q38309859
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials.Functional expression of human serum albumin-tandem thrombopoietin mimetic peptide fusion protein as a novel thrombopoietin analog in Pichia pastoris.Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice.GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice.Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists.GLP-1/glucagon receptor co-agonism for treatment of obesity.Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.TAT-HSA-α-MSH fusion protein with extended half-life inhibits tumor necrosis factor-α in brain inflammation of mice.Peptibodies: An elegant solution for a long-standing problem.Are peptide conjugates the golden therapy against obesity?
P2860

Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.

Item
http://www.wikidata.org/entity/Q38309859
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.
@en
type
label
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.
@en
prefLabel
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921